The cytotoxic effect of AF and olaparib monotherapy was investigated in a panel of NSCLC and PDAC cells with distinct p53 backgrounds and (mutant or WT) p53 protein levels (Table S1 and Figure S1A). Here, TP53 is linked to non-small cell lung carcinoma.